The Emory Biotech Consulting Club, founded by members of the Wuest Lab and supported in part by Dennis Liotta, is featured in a recent Emory News report. The article includes quotes from Henry Zecca (Jui Group) and Bill Wuest.
Young Emory scientists wanted a taste of what biotech business careers might be like. So they visited the world’s largest poultry industry conference, and got advice from officials at the Food and Drug Administration – all within a couple months.
“I learned a ton about chickens – more than I thought possible. I’ve been explaining it all to my friends,” says Henry Zecca, a graduate student in the Department of Chemistry.
Zecca’s experience and others emerged at a “Gala” Tuesday evening showcasing the Emory Biotech Consulting Club, which aimed to pair student advisory teams with fledgling startup companies emerging from university research.
The full article is available online from the Emory Report.
The Department of Chemistry at Emory University is pleased to welcome Bill Wuest to our faculty beginning in June 2017. Dr. Wuest joins Emory from Temple University where he was Daniel Swern Early Career Professor of Chemistry. At Emory, he will be the first Georgia Research Alliance (GRA) Distinguished Investigator in Emory College of Arts and Sciences. He will be joined at Emory by six graduate students–Erika Csatary, Colleen Keohane, Kelly Morrison, Sean Rossiter, Amy Solinski, Andrew Steele–and postdoc Sara Zahim.
Bill was born in Centereach, NY in 1981. He received his B.S. magna cum laude in Chemistry/Business from the University of Notre Dame in 2003. As an undergraduate, he investigated intramolecular hydroamination reactions under the tutelage of Professor Paul Helquist. Bill then moved to Philadelphia, PA to begin his graduate studies at the University of Pennsylvania working with Professor Amos B. Smith, III. His graduate work focused on both the total synthesis of peloruside A and the development of Anion Relay Chemistry (ARC) culminating with a Ph.D. in 2008. Bill then traveled to Harvard Medical School as a Ruth Kirschstein-NRSA Postdoctoral Fellow in the laboratory of Professor Christopher T. Walsh, where he investigated unusual enzymatic transformations in the construction of non-ribosomal peptide natural products.
In July of 2011, Bill began his independent career as an Assistant Professor at Temple University. His research focuses on the development of chemical tools to better understand bacteria with a specific focus on anti-virulence targets and narrow-spectrum therapeutics. He is also a member of the Molecular Therapeutics Division of Fox Chase Cancer Center and the Scientific Founder of NovaLyse BioSolutions, which seeks to commercialize the QAC technology developed in collaboration with the Minbiole Group at Villanova University. Bill is the recipient of a number of awards including the NIH ESI Maximizing Investigators Research Award (MIRA), NSF CAREER Award, the Young Investigator Award from the Center for Biofilm Engineering at Montana State University, the New Investigator Award from the Charles E. Kaufman Foundation, the Thieme Journal of Chemistry Award, and the Italia-Eire Foundation Distinguished Teacher of the Year Award from the College of Science and Technology at Temple University.
Bill is an avid sports fan, with allegiances to the NY Yankees, NY Giants, and his alma mater, the Notre Dame Fighting Irish. Outside the lab he enjoys spending time with his wife, Liesl, and son, Max.